Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
The type I IGF receptor as a target for breast cancer therapy
Xihong Zhang
,
Douglas Yee
Masonic Cancer Center
Medicine - Hematology, Oncology, Transplant
Office of Academic Clinical Affairs
Cellular Mechanisms of Cancer
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The type I IGF receptor as a target for breast cancer therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cancer Therapy
100%
Breast Cancer
100%
Somatomedin C Receptor
100%
Somatomedin
100%
Receptor
40%
Somatomedin Receptor
40%
Cancer Cell
20%
Phosphotransferase
20%
Cell Signaling Pathway
20%
Metastatic Carcinoma
20%
Cell Proliferation
20%
Systemic Therapy
20%
Growth Factor Receptor
20%
Neutralization
20%
Malignant Transformation
20%
Somatomedin Binding Protein
20%
Cell Death
20%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
20%
Monoclonal Antibody
20%
Trastuzumab
20%
Ligand Binding
20%
Keyphrases
Insulin-like
100%
Insulin-like Growth Factor 1 Receptor (IGF1R)
100%
Breast Cancer Treatment
100%
Growth Factors
55%
Growth Hormone Receptor
33%
Breast Cancer
22%
Factor System
22%
Novel Therapeutics
11%
Cell Proliferation
11%
Human Epidermal Growth Factor Receptor 2 (HER2)
11%
Monoclonal Antibody
11%
Signaling Pathway
11%
Malignant Transformation
11%
Breast Cancer Cells
11%
Trastuzumab
11%
Systemic Therapy
11%
Cell Death
11%
Therapeutic Potential
11%
Targeted Treatment
11%
Metastatic Breast Cancer
11%
Receptor Activation
11%
Kinase Activity
11%
Growth Factor Binding
11%
Binding Protein
11%
Downstream Signaling
11%
HER2-positive Breast Cancer
11%
Ligand Binding
11%
Epidemiological Evidence
11%
Signaling Cascades
11%
Humanized Antibody
11%
Targeting Strategies
11%
Successful Therapy
11%
Antibody Inhibition
11%
Ligand-receptor Interaction
11%
Antigrowth
11%
Factor Strategy
11%
Cell Metastasis
11%
Proliferation Protection
11%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Somatomedin C Receptor
100%
Somatomedin
100%
Receptor
40%
Somatomedin Receptor
40%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
20%
Phosphotransferase
20%
Somatomedin Binding Protein
20%
Growth Factor Receptor
20%
Monoclonal Antibody
20%
Malignant Transformation
20%
Trastuzumab
20%
Immunology and Microbiology
Somatomedin
100%
Insulin-Like Growth Factor 1 Receptor
100%
Growth Factor
12%
Neutralization
12%
Monoclonal Antibody
12%
Cancer Cell
12%
Trastuzumab
12%
Cell Proliferation
12%
Cell Death
12%
Humanized Antibody
12%
Protein Binding
12%
Ligand Binding
12%